PE20000049A1 - Nuevos macrolidos - Google Patents

Nuevos macrolidos

Info

Publication number
PE20000049A1
PE20000049A1 PE1998001287A PE00128798A PE20000049A1 PE 20000049 A1 PE20000049 A1 PE 20000049A1 PE 1998001287 A PE1998001287 A PE 1998001287A PE 00128798 A PE00128798 A PE 00128798A PE 20000049 A1 PE20000049 A1 PE 20000049A1
Authority
PE
Peru
Prior art keywords
alkyl
group
alkinyl
alkenyl
members
Prior art date
Application number
PE1998001287A
Other languages
English (en)
Inventor
John Philip Dirlam
Arthur Hamish Alastair Irvine Mc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20000049A1 publication Critical patent/PE20000049A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE REFIERE A NUEVOS ANALOGOS DE ERITROMICINA Y AZALIDAS DE FORMULA I; Y ES H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R1 ES ALQUILO, ALQUENILO, ALQUINILO, ALCOXIALQUILO, FENILO OPCIONALMENTE SUSTITUIDO, GRUPO a, -CH2R24, ENTRE OTROS; X ES O, S, -CH2-; a, b, c, d SON 0-2; a+b+c+d¾5; R24 ES H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R2 ES H u OH; R3 ES H, OH u OCH3; R4 ES H, -COR9, COOR9, CONR9R10, UN GRUPO PROTECTOR DE OH; R5 ES -SR8, -(CH2)nCOR8, ALQUILO C1-C10, ENTRE OTROS; n ES 0-1; R8 ES H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; CUANDO R8 ES -CH2NR8R15, R8 Y R15 FORMAN JUNTOS UN ANILLO MONO O POLICICLICO DE 4 A 10 MIEMBROS, HETEROCICLO DE 5-10 MIEMBROS, ENTRE OTROS; R18 ES OH, R19 ES ALQUILO C1-C10, ALQUENILO C2-C10, ALQUINILO C2-C10, ENTRE OTROS; O R18 Y R19 FORMAN JUNTOS UN ANILLO OXAZOLILO; R20 ES H, UN GRUPO b. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION DEL COMPUESTO I Y COMPUESTOS INTERMEDIOS. EL COMPUESTO I PUEDE SER UTIL PARA TRATAR UNA INFECCION BACTERIANA O INFECCION PROTOZOARIA Y OTRAS APLICACIONES COMO CANCER, ATEROSCLEROSIS, REDUCCION DE LA MOTILIDAD GASTRICA
PE1998001287A 1998-01-02 1998-12-28 Nuevos macrolidos PE20000049A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7034398P 1998-01-02 1998-01-02

Publications (1)

Publication Number Publication Date
PE20000049A1 true PE20000049A1 (es) 2000-02-07

Family

ID=22094723

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001287A PE20000049A1 (es) 1998-01-02 1998-12-28 Nuevos macrolidos

Country Status (34)

Country Link
US (2) US6472371B1 (es)
EP (1) EP1044207A1 (es)
JP (1) JP2002500230A (es)
KR (1) KR100352809B1 (es)
CN (1) CN1284081A (es)
AP (1) AP9801420A0 (es)
AR (4) AR014948A1 (es)
AU (1) AU756409B2 (es)
BG (1) BG104644A (es)
BR (1) BR9814601A (es)
CA (1) CA2316919C (es)
CO (1) CO4970821A1 (es)
CZ (1) CZ20002458A3 (es)
DZ (1) DZ2698A1 (es)
EA (1) EA200000594A1 (es)
GT (1) GT199800206A (es)
HR (1) HRP20000442A2 (es)
HU (1) HUP0100420A3 (es)
IL (1) IL137024A0 (es)
IS (1) IS5528A (es)
MA (1) MA24729A1 (es)
NO (1) NO20003347L (es)
NZ (1) NZ504986A (es)
OA (1) OA11438A (es)
PA (1) PA8465301A1 (es)
PE (1) PE20000049A1 (es)
PL (1) PL341642A1 (es)
SK (1) SK9782000A3 (es)
TN (1) TNSN98238A1 (es)
TW (1) TW520374B (es)
UY (2) UY25330A1 (es)
WO (1) WO1999035156A1 (es)
YU (1) YU41500A (es)
ZA (1) ZA9811939B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
EP1754700A3 (en) 1999-01-27 2007-05-09 Kosan Biosciences, Inc. Synthesis of oligoketides
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
JP2002542197A (ja) 1999-04-16 2002-12-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ケトライド抗菌剤
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
OA11945A (en) 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
JPWO2003072589A1 (ja) * 2002-02-26 2005-06-16 明治製菓株式会社 新規１５員環アザライド及び新規１６員環ジアザライド誘導体とその製造法
ES2314724T3 (es) 2004-09-23 2009-03-16 Schering-Plough Ltd. Control de parasitos en animales mediante el uso de nuevos derivados de eter de trifluorometanosulfonanilida oxima.
CA2587495A1 (en) * 2004-11-19 2006-05-26 Schering-Plough Ltd. Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
UA85937C2 (uk) 2004-12-21 2009-03-10 Пфайзер Продактс Інк. Макроліди
MX2007015729A (es) * 2005-06-09 2008-02-21 Schering Plough Ltd Control de parasitos en animales con derivados de n-[(feniloxi)fenil]-1,1,1-trifluorometansulfonamida y de n[(fenilsulfanil)fenil]-1,1,1-trifluorometansulfonamida.
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
WO2008076259A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
CN101600686A (zh) * 2006-12-13 2009-12-09 先灵-普劳有限公司 氯霉素、甲砜霉素及其类似物的水溶性前药
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
ES2549731T3 (es) 2007-06-27 2015-11-02 E. I. Du Pont De Nemours And Company Método para el control de plagas en animales
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
TWI401023B (zh) 2008-02-06 2013-07-11 Du Pont 中離子農藥
JP2011529895A (ja) * 2008-07-30 2011-12-15 インターベツト・インターナシヨナル・ベー・ベー フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
JP2013501063A (ja) 2009-08-05 2013-01-10 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー メソイオン性殺虫剤
UA107804C2 (en) 2009-08-05 2015-02-25 Du Pont Mixtures of pesticides mezoionnyh
EP2461684A2 (en) 2009-08-05 2012-06-13 E. I. du Pont de Nemours and Company Mesoionic pesticides
UA110924C2 (uk) 2009-08-05 2016-03-10 Е. І. Дю Пон Де Немур Енд Компані Мезоіонні пестициди
UY33397A (es) 2010-05-27 2011-12-01 Du Pont Forma sólida de un naftaleno carboxamida
WO2012087630A1 (en) 2010-12-20 2012-06-28 E.I. Du Pont De Nemours And Company Pyridine and pyrimidine compounds for controlling invertebrate
JPWO2012105562A1 (ja) * 2011-01-31 2014-07-03 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規マクロライド誘導体
JP2014520151A (ja) 2011-06-20 2014-08-21 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 蠕虫感染を処置するためのヘテロ環式化合物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
CN103958476A (zh) 2011-11-28 2014-07-30 纳幕尔杜邦公司 N-(4-喹啉基甲基)磺酰胺衍生物以及它们作为驱肠虫剂的用途
WO2013158422A1 (en) 2012-04-17 2013-10-24 E. I. Du Pont De Nemours And Company Heterocyclic compounds for controlling invertebrate pests
WO2014099837A1 (en) 2012-12-18 2014-06-26 E. I. Du Pont De Nemours And Company Sulfonamide anthelmintics
CN103965273B (zh) * 2013-08-23 2016-05-25 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN105669798B (zh) * 2013-08-23 2019-07-26 普莱柯生物工程股份有限公司 一种大环内酯类化合物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652537A (en) 1969-11-21 1972-03-28 Lilly Co Eli Epierythromycylamine and epierythromycyl b amine
US3923784A (en) 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4585759A (en) 1985-01-22 1986-04-29 Pfizer Inc. Antibacterial derivatives of a neutral macrolide
HU198913B (en) * 1987-09-03 1989-12-28 Pliva Pharm & Chem Works Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
US5141926A (en) 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
US5824513A (en) 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
WO1993013663A1 (en) 1992-01-17 1993-07-22 Abbott Laboratories Method of directing biosynthesis of specific polyketides
US5985844A (en) 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2065218A1 (en) 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
US5523399A (en) 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
FR2691464B1 (fr) * 1992-05-21 1995-06-02 Roussel Uclaf Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US6271255B1 (en) 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
AU6932098A (en) 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
US6407074B1 (en) 1997-06-11 2002-06-18 Pfizer Inc C-4″-substituted macrolide derivatives
US20020025937A1 (en) 2000-03-20 2002-02-28 Yong-Jin Wu 9-oxime erythromycin derivatives
WO1999000124A1 (en) 1997-06-26 1999-01-07 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
HN1998000159A (es) 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
PA8461401A1 (es) 1997-10-29 2000-05-24 Pfizer Prod Inc Derivados de eritromicina triciclicos
AP9801420A0 (en) 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
PT941998E (pt) 1998-03-03 2004-12-31 Pfizer Prod Inc Antibioticos macrolidos do tipo 3,6-cetal
WO1999062920A1 (en) 1998-06-03 1999-12-09 Pfizer Products Inc. Tricyclic 3-keto derivatives of 6-o-methylerythromycin
US6043227A (en) 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CN1376160A (zh) 1998-11-03 2002-10-23 辉瑞产品公司 新的大环内酯抗生素
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
OA11945A (en) 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
EP1101769A3 (en) 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives
WO2003014136A1 (en) 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME

Also Published As

Publication number Publication date
TW520374B (en) 2003-02-11
KR100352809B1 (ko) 2002-11-01
EA200000594A1 (ru) 2001-04-23
DZ2698A1 (fr) 2003-03-29
HRP20000442A2 (en) 2001-04-30
PL341642A1 (en) 2001-04-23
WO1999035156A1 (en) 1999-07-15
US6472371B1 (en) 2002-10-29
CA2316919C (en) 2004-10-26
CA2316919A1 (en) 1999-07-15
BR9814601A (pt) 2000-10-17
BG104644A (en) 2001-01-31
PA8465301A1 (es) 2000-09-29
CZ20002458A3 (cs) 2001-10-17
UY25574A1 (es) 1999-09-27
AR014948A1 (es) 2001-04-11
HUP0100420A3 (en) 2003-07-28
OA11438A (en) 2004-04-30
SK9782000A3 (en) 2001-12-03
HUP0100420A2 (hu) 2001-07-30
CO4970821A1 (es) 2000-11-07
MA24729A1 (fr) 1999-07-01
NO20003347D0 (no) 2000-06-27
AR020551A2 (es) 2002-05-15
AP9801420A0 (en) 1998-12-31
US20040092459A1 (en) 2004-05-13
UY25330A1 (es) 2000-12-29
GT199800206A (es) 2000-06-21
KR20010024818A (ko) 2001-03-26
NZ504986A (en) 2003-03-28
TNSN98238A1 (fr) 2005-03-15
IL137024A0 (en) 2001-06-14
ZA9811939B (en) 2000-06-30
AU1444799A (en) 1999-07-26
US7015203B2 (en) 2006-03-21
AR020851A2 (es) 2002-05-29
WO1999035156B1 (en) 1999-10-21
AU756409B2 (en) 2003-01-09
NO20003347L (no) 2000-08-28
YU41500A (sh) 2003-02-28
JP2002500230A (ja) 2002-01-08
IS5528A (is) 2000-06-09
EP1044207A1 (en) 2000-10-18
AR019787A2 (es) 2002-03-13
CN1284081A (zh) 2001-02-14

Similar Documents

Publication Publication Date Title
PE20000049A1 (es) Nuevos macrolidos
PE79699A1 (es) Derivados de 9-desoxo-9a-aza-9a-homoeritromicina a c-4" sustituidos
ECSP014101A (es) Compuestos organicos
AR247415A1 (es) Composiciones organopolisiloxanicas curables con catalizadores de estano (iv)
BR9405965A (pt) Derivados de 10,11-metanodibenzossuberano usados como agentes de quimiossensibilização
AR012032A1 (es) Compuestos derivados 3'-n-oxido, 3'-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion
AR018633A1 (es) Derivados de benzo(b)tiepin-1,1-dioxido, procedimiento para su preparacion, medicamentos conteniendo estos compuestos y su empleo
FI865037A7 (fi) Mikrobicida kompositioner.
PE79999A1 (es) Derivados de macrolidos c-4" sustituidos
ATE7300T1 (de) Alkylierte verbindungen von c-076-verbindungen, verfahren zu deren herstellung und deren verwendung als antiparasitische mittel.
ES2071334T3 (es) Analogos de anillos fusionados de nitrogeno conteniendo heterociclos no aromaticos.
BR8707408A (pt) Novos 5-alcoxi-2,4-diamino-alquibenzenos e composicoes de tingimento de cabelo com 5-alcoxi-2,4-diamino-alquil-benzenos
ES481220A1 (es) Un procedimiento para la preparacion de 2-aril-aminotiazo- les.
NZ504987A (en) Erythromycin derivatives
SE7602122L (sv) Nya piperazinyliminorifamyciner och sett att framstella desamma
MX9700871A (es) Procedimiento para hacer compuestos antimicrobianos.
AR015369A1 (es) Composiciones aditivas de lavanderia que se activan en el secarropas y provistas con agentes protectores del color, articulos de lavanderia que lascontienen y metodo para lavar
DE60229054D1 (de) Synthese von zyklopentadien derivaten
ES2108862T3 (es) Diamidas imidocarbonimidicas n,n' substituidas derivadas de hidroxilaminas.
TR200201783T2 (tr) 5-Siyanofatalid hazırlamak için yöntem
MX9307592A (es) Fosfitos y fosfonitos oligomericos de aminas impedidas como estabilizadores contra la luz.
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
FI955085A0 (fi) Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ATE447949T1 (de) Vakuolar-typ (h+)-atpase-hemmende verbindungen, zusammensetzungen und deren verwendungen
ES2102327B1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion.

Legal Events

Date Code Title Description
FC Refusal